Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management (Q33532262)

27 July 2017

1 reference

title

Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management (English)

1 reference

inflammatory bowel diseases

27 July 2017

0 references

0 references

1 reference

Ole Haagen Nielsen

3

0 references

author name string

Signe Larsen

series ordinal

1

1 reference

PubMed ID

20166813

27 July 2017

Klaus Bendtzen

series ordinal

2

1 reference

PubMed ID

20166813

27 July 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

27 July 2017

1 reference

27 July 2017

42

1 reference

27 July 2017

97-114

1 reference

27 July 2017

2

1 reference

Extraintestinal manifestations of inflammatory bowel diseases

27 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Therapy insight: how the gut talks to the joints--inflammatory bowel disease and the spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Extraintestinal manifestations in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Insights into the pathology and treatment of spondyloarthritis: from the bench to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

The treatment of the rheumatological manifestations of the inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Inflammatory bowel disease genetics: Nod2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Prevention and treatment of osteoporosis in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Reduced bone density in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Evolution of osteopenia in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

A controlled study of bone mineral density in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

The pathophysiology of bone disease in gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Osteomalacia after small-intestinal resection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Metabolic bone disease in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Important cutaneous manifestations of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Therapy Insight: pyoderma gangrenosum-old disease, new management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Pyoderma gangrenosum: classification and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Non-IBD and noninfectious colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Azathioprine hypersensitivity presenting as a neutrophilic dermatosis in a man with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Crohn's disease associated with Sweet's syndrome and Sjögren's syndrome treated with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Inflammatory bowel disease and the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Ocular manifestations of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Episcleritis and scleritis: clinical features and treatment results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Rituximab for treatment of ocular inflammatory disease: a series of four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Biologic agents in the management of inflammatory eye diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Genetic epidemiology of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Current treatments of primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Gall Stones in Patients with Disorders of the Terminal Ileum and Disturbed Bile Salt Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Gallstones in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Gallstone disease and related risk factors in patients with Crohn disease: analysis of 330 consecutive cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Prevalence of cholelithiasis in patients with chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Treatment of gallstones by extracorporeal shock wave lithotripsy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Anemia in IBD: the overlooked villain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Occult gastrointestinal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Anemia in patients with chronic inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Thrombosis and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Venous thromboembolism in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Drug insight: aminosalicylates for the treatment of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

21 January 2018

Homocysteine metabolism

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Practice guidelines in acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Risk factors for developing renal stones in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Management of kidney stones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Randomized trial of allopurinol in the prevention of calcium oxalate calculi.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Meta-Analysis of Randomized Trials for Medical Prevention of Calcium Oxalate Nephrolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Pulmonary involvement in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Bronchial disease in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Pulmonary Function Tests and High-Resolution CT in the Detection of Pulmonary Involvement in Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Chronic cough due to bronchiectasis: ACCP evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Inflammatory bowel disease in the setting of autoimmune pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Drug-induced pancreatitis : incidence, management and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Pancreatic Autoantibodies in Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Comparative tolerability of treatments for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Incidence and risk factors for gallstones in patients with inflammatory bowel disease: A large case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

Extraintestinal Manifestations of Crohn’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903559724

10.3109/07853890903559724

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference

PubMed ID

20166813